中国远大集团有限责任公司简介中英文版.doc
![资源得分’ title=](/images/score_1.gif)
![资源得分’ title=](/images/score_1.gif)
![资源得分’ title=](/images/score_1.gif)
![资源得分’ title=](/images/score_1.gif)
![资源得分’ title=](/images/score_05.gif)
《中国远大集团有限责任公司简介中英文版.doc》由会员分享,可在线阅读,更多相关《中国远大集团有限责任公司简介中英文版.doc(5页珍藏版)》请在淘文阁 - 分享文档赚钱的网站上搜索。
1、【精品文档】如有侵权,请联系网站删除,仅供学习与交流中国远大集团有限责任公司简介中英文版.精品文档.中国远大集团有限责任公司简介Company Profile of China Grand Enterprises, Inc.窗体顶端窗体底端中国远大集团有限责任公司(以下简称中国远大集团)成立于1993年,系股份制集团公司,总部位于北京亚运村远大中心。作为一家经营管理型投资公司,中国远大集团主营业务涵盖医药健康、置业投资、贸易产业及金融服务等产业领域。China Grand Enterprises, Inc. (hereinafter referred to as CGE), establish
2、ed in 1993, is a joint-stock group company, headquartered in Grand Place, Beijing Asian Games Village. As an investment company engaged in operation and management, CGEs core businesses cover pharmaceuticals and healthcare, property investment, commercial trade business, financial services and other
3、 industries.窗体底端1、医药健康产业在医药健康产业领域,中国远大集团已形成以华东医药股份有限公司为龙头企业的发酵技术产业发展平台,以远大医药(中国)有限公司为龙头企业的化学合成药产业发展平台,以拥有近三百年历史的雷允上药业集团公司为龙头企业的现代中药产业发展平台,以远大蜀阳药业为龙头企业的血液制品、生物疫苗及生物制药产业发展平台;提供化学制剂、中药制剂、以血液制品及疫苗为基础的生物制剂等三大类近千品种的成药制剂品种;生产多种大宗原料药和甾体激素类、肾上腺素类等多种特色原料药、精细化工中间体和保健品等多个类别的医药相关产品;已形成各专业领域的营销体系,多项产品通过欧洲COS认证和美国
4、FDA认证。中国远大集团一直将医药新产品研发作为战略重点,持续投入专项资金,通过构建自主研发平台,产学研相结合和国际合作等多种方式,不断成功开发出新产品投放市场;已经形成了集产品研发、生产、销售于一体,中西药并举,国际和国内市场共同发展的医药健康产业模式。1. Pharmaceuticals and Healthcare IndustryIn the field of pharmaceuticals and healthcare industry, CGE has established several core industrial platforms within her controll
5、ed subsidiary companies. These include Huadong Pharmaceutical Co. Ltd. that plays a leading role in fermentation-based pharmaceutical production, Grand Pharma (China) Co. Ltd. a leader in synthetic chemistry-based pharmaceutical production, Lei Yunshang Pharmaceutical Group with a nearly 300-year hi
6、story operating in the production of modern Traditional Chinese Medicine, and Grand Shuyang Pharmaceutical Co., Ltd. focusing on the production of blood products, vaccines and other biopharmaceutical products. CGE pharmaceutical and healthcare industry produces nearly a thousand pharmaceutical produ
7、cts which belong to three major categories including synthetic chemical drugs, traditional Chinese medicines and biopharmaceuticals consisting mainly of blood products and vaccines. Among the products of CGE pharmaceutical and healthcare industry are included various bulk active pharmaceutical ingre
8、dients (APIs), steroid hormones, adrenalines and a variety of other specialty APIs, fine chemicals and chemical intermediates, healthcare products and various other classes of pharmaceutical related products. CGE pharmaceutical and healthcare industry has established marketing systems in various spe
9、cific fields, and many products have passed European COS certifications and US FDA inspections.CGE views her pharmaceutical R&D as having strategic importance and continues to invest a large amount of funds in specific areas. Multiple approaches through the build-up of internal R&D capacity, establi
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 中国 远大 集团有限责任 公司简介 中英文
![提示](https://www.taowenge.com/images/bang_tan.gif)
限制150内